STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)
Clinical trial NCT02722369 · TERMINATED
Trial details
- NCT number
- NCT02722369
- Sponsor
- University College, London
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2021-03-12
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.